Literature DB >> 12956430

PPARgamma--an important regulator of monocyte/macrophage function.

Andreas von Knethen1, Bernhard Brüne.   

Abstract

Regulation of monocyte/macrophage function is important in coordinating immune responses. Their contact with invading pathogens activates signaling pathways that provoke pro-inflammatory gene expression and thus causing a locally restricted inflammation. Recently, the peroxisome proliferator-activated receptor gamma (PPARgamma) has been identified to antagonize pro-inflammatory responses in monocytes/macrophages, causing an anti-inflammatory and/or desensitized phenotype to predominate. For PPARgamma, the general mechanisms facilitating the transition from a pro- to an anti-inflammatory phenotype have been elucidated. PPARgamma is a member of the nuclear receptor superfamily and is activated upon endogenous as well as exogenous agonist binding. Here we focus on its role in monocyte/macrophage biology in affecting inflammation. Summarizing current information, a model is proposed which gives rise to potential new therapeutic possibilities for the treatment of diseases presumably involving PPARgamma-dependent regulatory circuits.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12956430

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  5 in total

1.  Sumoylation of peroxisome proliferator-activated receptor gamma by apoptotic cells prevents lipopolysaccharide-induced NCoR removal from kappaB binding sites mediating transrepression of proinflammatory cytokines.

Authors:  Carla Jennewein; Anne-Marie Kuhn; Martina Victoria Schmidt; Virginie Meilladec-Jullig; Andreas von Knethen; Frank J Gonzalez; Bernhard Brüne
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

2.  α-Mangostin Alleviated Inflammation in Rats With Adjuvant-Induced Arthritis by Disrupting Adipocytes-Mediated Metabolism-Immune Feedback.

Authors:  Ying-Hao Hu; Jun Han; Lin Wang; Chao Shi; Yan Li; Opeyemi Joshua Olatunji; Xiu Wang; Jian Zuo
Journal:  Front Pharmacol       Date:  2021-07-07       Impact factor: 5.810

3.  The Current Knowledge of the Role of PPAR in Hepatic Ischemia-Reperfusion Injury.

Authors:  M Elias-Miró; M B Jiménez-Castro; M Mendes-Braz; A Casillas-Ramírez; C Peralta
Journal:  PPAR Res       Date:  2012-05-16       Impact factor: 4.964

4.  Acidic Microenvironment Aggravates the Severity of Hepatic Ischemia/Reperfusion Injury by Modulating M1-Polarization Through Regulating PPAR-γ Signal.

Authors:  Wei Ding; Yunfei Duan; Zhen Qu; Jiawei Feng; Rongsheng Zhang; Xiaodong Li; Donglin Sun; Xiaoying Zhang; Yunjie Lu
Journal:  Front Immunol       Date:  2021-06-21       Impact factor: 7.561

5.  An ophthalmic solution of a peroxisome proliferator-activated receptor gamma agonist prevents corneal inflammation in a rat alkali burn model.

Authors:  Masaaki Uchiyama; Akira Shimizu; Yukinari Masuda; Shinya Nagasaka; Yuh Fukuda; Hiroshi Takahashi
Journal:  Mol Vis       Date:  2013-11-01       Impact factor: 2.367

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.